Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p01041707/Active-Pharmaceutical-Ingredients-APIs-Market-in-Asia-Pacific-to-2017---Increasing-Penetration-in-China-and-India-Coupled-with-Low-Cost-Manufacturing-to-Fuel-Regional-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=IT_Hosting

Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

Asia-Pacific is the second largest regional market for APIs by revenue in the world. The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue standing at $108,613m. Total revenue generated by the Asia-Pacific API market was $30,693m in 2011, and is expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017. This will be supported by healthy demand from the biotech and generic API sectors.

Scope

- Market revenue data for APIs from 2005 to 2011 and forecasts for six years to 2017. - API markets in key countries in the region, including Japan, China, South Korea and India.- API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region. - Drivers of the API market, such as the growth of generic drugs, and restraints.- Detailed historic and forecast trends and share analysis of API revenue, based on product types (synthetic and biotech APIs) in the Asia-Pacific market, and in key countries of the region. - Detailed historic and forecast trends and share analysis of API revenue, based on customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) in the Asia-Pacific market, and in key countries of the region. - Analysis of API revenue based on therapeutic categories at a regional and key country level.

Reasons to buy

- Develop business strategies with the help of specific insights on the Asia-Pacific API market. - Identify opportunities and challenges in the Asia-Pacific API market. - Invest in the growing segments of the API market. - Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Asia-Pacific API market. - Benchmark your operations and strategies against the major players in the global API market.1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 92 Introduction 103 Contract Manufacturing Organizations (CMO) 113.1 Process of CMO Outsourcing 113.2 Asia-Pacific CMO Market Drivers 123.2.1 Availability of Low-cost Skilled Manpower 123.2.2 Key Benefits of Outsourcing 133.3 Asia-Pacific CMO Market Revenues and Forecast to 2017 144 Asia-Pacific Active Pharmaceutical Ingredients Market 164.1 Asia-Pacific API Industry Structure 164.2 Asia-Pacific API Distribution Structure 174.3 Asia-Pacific API Market Overview 184.4 Asia-Pacific APIs Market Segmentation 194.4.1 Synthetic APIs 194.4.2 Biotech APIs 204.5 Asia-Pacific APIs Market Drivers 204.5.1 Growing Pharmaceutical Manufacturing Capabilities of Developing Countries Such as China and India are Attracting APIs Manufacturing from Developed Countries 204.5.2 Domestic Market Growth of Developing Countries in Asia-Pacific is Providing Global Pharmaceutical Industry Growth 204.5.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute Significantly to Asia-Pacific APIs Market Growth 204.5.4 The Improving Regulatory Framework in Markets of China and India is Increasing the Penetration of Branded Drugs 214.5.5 Patent Expiries of Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific 214.6 Asia-Pacific APIs Market Restraints 214.6.1 Increasing Patent Expiries Hamper the Growth of the Branded API Market 214.6.2 Highly Fragmented Market Restricts the Revenue Growth of the Asia-Pacific API Market 214.6.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 214.6.4 High Currency Fluctuations Hamper the Value Growth of the Pharmaceutical Market in the Asia-Pacific Region 224.7 Asia-Pacific APIs Market Revenue and Forecasts to 2017 224.8 Asia-Pacific Revenue Share Analysis by Product Types 244.9 Asia-Pacific Synthetic APIs Market 254.9.1 Asia-Pacific Synthetic APIs Market Drivers 254.9.2 Asia-Pacific Synthetic APIs Market Restraints 254.9.3 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 264.9.4 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 314.9.5 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 324.10 Asia-Pacific Biotech APIs Market 344.10.1 Asia-Pacific Biotech APIs Market Drivers 344.10.2 Asia-Pacific Biotech APIs Market Restraints 344.10.3 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 354.10.4 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 404.10.5 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 414.11 Asia-Pacific Patent Expiry of Leading Biologics 434.12 Asia-Pacific APIs Market Share Analysis by Therapeutic Applications 445 Japan Active Pharmaceutical Ingredients Market 465.1 Japan APIs Market Overview 465.2 Japan APIs Market Revenue and Forecasts to 2017 465.3 Japan APIs Market Revenue Share Analysis by Product Type 485.4 Japan APIs Market by Customer Base 495.4.1 Japan Synthetic Market Revenue by Customer Base and Forecasts to 2017 495.4.2 Japan Synthetic Market Revenue Share Analysis by Customer Base 515.4.3 Japan Biotech Market Revenue by Customer Base and Forecasts to 2017 525.4.4 Japan Biotech Market Revenue Share Analysis by Customer Base 545.5 Japan APIs Market Share Analysis by Therapeutic Applications 556 China Active Pharmaceutical Ingredients Market 566.1 China APIs Market Overview 566.2 China API Market Revenues by Product Type and Forecasts to 2017 566.3 China APIs Market Revenue Share Analysis by Product Types 596.4 China APIs Market by Customer Base 606.4.1 China Synthetic Market Revenue by Customer Base and Forecasts to 2017 606.4.2 China Synthetic Market Revenue Share Analysis by Customer Base 626.4.3 China Biotech Market Revenue by Customer Base and Forecast to 2017 636.4.4 China Biotech Market Revenue Share Analysis by Customer Base 656.5 China APIs Market Share Analysis by Therapeutic Applications 667 South Korea Active Pharmaceutical Ingredients Market 687.1 South Korea APIs Market Overview 687.2 South Korea APIs Market Revenue and Forecasts to 2017 687.3 South Korea APIs Market Revenue Share Analysis by Product Type 717.4 South Korea APIs Market by Customer Base 727.4.1 South Korea Synthetic Market Revenue by Customer Base and Forecasts to 2017 727.4.2 South Korea Synthetic Market Revenue Share Analysis by Customer Base 757.4.3 South Korea Biotech Market Revenue by Customer Base and Forecasts to 2017 767.4.4 South Korea Biotech Market Revenue Share Analysis by Customer Base 787.5 South Korea APIs Market Share Analysis by Therapeutic Applications 798 India Active Pharmaceutical Ingredients Market 818.1 India APIs Market Overview 818.2 India APIs Market Revenue and Forecasts to 2017 818.3 India APIs Market Revenue Share Analysis by Product Types 848.4 India APIs Market by Customer Base 858.4.1 India Synthetic Market Revenue by Customer Base and Forecasts to 2017 858.4.2 India Synthetic Market Revenue Share Analysis by Customer Base 878.4.3 India Biotech Market Revenue by Customer Base and Forecasts to 2017 888.4.4 India Biotech Market Revenue Share Analysis by Customer Base 908.5 India APIs Market Revenue Analysis by Therapeutic Applications 919 Appendix 939.1 Abbreviations 939.2 Bibliography 939.3 Market Definitions 949.4 Methodology 949.4.1 Coverage 949.4.2 Secondary Research 949.4.3 Primary Research 959.4.4 Expert Panel Validation 959.5 Contact Us 959.6 Disclaimer 95

1.1 List of Tables

Table 1: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011 13Table 2: CMO Market, Asia-Pacific, Revenues, $m, 2005-2017 15Table 3: APIs Market, Asia-Pacific, Market Revenues, $m, 2005-2017 23Table 4: APIs Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 24Table 5: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005-2017 27Table 6: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 28Table 7: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries ($m), 2005, 2011 and 2017 31Table 8: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 32Table 9: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005-2017 33Table 10: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005-2017 36Table 11: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 37Table 12: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017 40Table 13: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011 41Table 14: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005-2017 42Table 15: Biotech Market , Asia-Pacific, Key Patent Expiries, 2004-2018 43Table 16: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017 45Table 17: APIs Market, Japan, Market Revenues by Product Types, $m, 2005-2017 47Table 18: APIs Market, Japan, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017 48Table 19: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 50Table 20: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005, 2011 and 2017 51Table 21: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 53Table 22: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 54Table 23: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2011-2017 55Table 24: APIs Market, China, Market Revenues by Product Type, $m, 2005-2017 58Table 25: APIs Market, China, Revenue Share Analysis by Product Type, %, 2005, 2011 and 2017 59Table 26: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005-2017 61Table 27: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017 62Table 28: Biotech Market, China, Market Revenues by Customer Base, $m, 2005-2017 64Table 29: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 65Table 30: APIs Market, China, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017 67Table 31: APIs Market, South Korea, Market Revenues by Product Types, $m, 2005-2017 70Table 32: APIs Market, South Korea, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017 72Table 33: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 74Table 34: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 76Table 35: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 77Table 36: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 79Table 37: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017 80Table 38: APIs Market, India, Market Revenues by Product Types, $m, 2005-2017 83Table 39: APIs Market, India, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017 84Table 40: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005-2017 86Table 41: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 87Table 42: Biotech Market, India, Market Revenues by Customer Base, $m, 2005-2017 89Table 43: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017 90Table 44: APIs Market, India, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017 92

1.2 List of Figures

Figure 1: CMO Market, Global, CMO Process Selection and Outsourcing Project Management 11Figure 2: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011 12Figure 3: CMO Market, Key Benefits of CMO Outsourcing 13Figure 4: CMO Market, Asia-Pacific, Revenue Forecasts ($m), 2005-2017 14Figure 5: APIs Market, Asia-Pacific, Industry Value Chain 16Figure 6: APIs Market, Asia-Pacific, Distribution Structure 17Figure 7: APIs Market, Asia-Pacific, Product Types 19Figure 8: APIs Market, Asia-Pacific, Market Revenues ($m), 2005-2017 22Figure 9: APIs Market, Asia-Pacific, Revenue Share by Product Types (%), 2011 24Figure 10: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005-2017 26Figure 11: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 28Figure 12: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005-2017 29Figure 13: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005, 2011 and 2017 30Figure 14: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 31Figure 15: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Types ($m), 2005-2017 32Figure 16: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005-2017 35Figure 17: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 37Figure 18: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005-2017 38Figure 19: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005, 2011 and 2017 39Figure 20: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011 40Figure 21: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005-2017 41Figure 22: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017 44Figure 23: APIs Market, Japan, Market Revenues by Product Types ($m), 2005-2017 46Figure 24: APIs Market, Japan, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017 48Figure 25: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 49Figure 26: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005, 2011 and 2017 51Figure 27: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 52Figure 28: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 54Figure 29: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications (%), 2011-2017 55Figure 30: APIs Market, China, Market Revenues by Product Type ($m), 2005-2017 57Figure 31: APIs Market, China, Revenue Share Analysis by Product Type (%), 2005, 2011 and 2017 59Figure 32: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005-2017 60Figure 33: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017 62Figure 34: Biotech Market, China, Market Revenues by Customer Base ($m), 2005-2017 63Figure 35: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 65Figure 36: APIs Market, China, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017 66Figure 37: APIs Market, South Korea, Market Revenues by Product Types ($m), 2005-2017 69Figure 38: APIs Market, South Korea, Revenues Share Analysis by Product Types (%), 2005, 2011 and 2017 71Figure 39: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 73Figure 40: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 75Figure 41: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 76Figure 42: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 78Figure 43: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017 79Figure 44: APIs Market, India, Market Revenues by Product Types ($m), 2005-2017 82Figure 45: APIs Market, India, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017 84Figure 46: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005-2017 85Figure 47: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 87Figure 48: Biotech Market, India, Market Revenues by Customer Base ($m), 2005-2017 88Figure 49: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017 90Figure 50: APIs Market, India, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017 91

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker